454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8

Por Ofek, G, Zhu, J, Yang, Y, Zhang, B, Mckee, K, Louder, M, Huang, J, Laub, L, Connors, M, Mascola, J, Kwong, PD
Publicado em 2012

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies

Por Joyce, M, Zhang, B, Zhou, T, Moquin, S, Wu, X, Louder, M, Zhang, Z, Georgiev, I, Zhu, J, Shapiro, L, Mascola, JR, Nabel, GJ, Kwong, PD
Publicado em 2012

Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 a...

Por Mascola, J R, Louder, M K, VanCott, T C, Sapan, C V, Lambert, J S, Muenz, L R, Bunow, B, Birx, D L, Robb, M L
Publicado em 1997

Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization

Por Asokan, M., Rudicell, R. S., Louder, M., McKee, K., O'Dell, S., Stewart-Jones, G., Wang, K., Xu, L., Chen, X., Choe, M., Chuang, G., Georgiev, I. S., Joyce, M. G., Kirys, T., Ko, S., Pegu, A., Shi, W., Todd, J. P., Yang, Z., Bailer, R. T., Rao, S., Kwong, P. D., Nabel, G. J., Mascola, J. R.
Publicado no J Virol (2015)

Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults

Por Ledgerwood, J E, Coates, E E, Yamshchikov, G, Saunders, J G, Holman, L, Enama, M E, DeZure, A, Lynch, R M, Gordon, I, Plummer, S, Hendel, C S, Pegu, A, Conan-Cibotti, M, Sitar, S, Bailer, R T, Narpala, S, McDermott, A, Louder, M, O'Dell, S, Mohan, S, Pandey, J P, Schwartz, R M, Hu, Z, Koup, R A, Capparelli, E, Mascola, J R, Graham, B S
Publicado no Clin Exp Immunol (2015)